Viva Biotech Accelerates AI-Driven Drug Discovery and Advance the 'Lab-in-the-Loop' with NVIDIA

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Viva-AIDriven-Drug

More Like This

PR Newswire associated0

Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery

PR Newswire associated0

Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry

PR Newswire associated0

Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities

PR Newswire associated0

LenioBio partners with AffinityAI to accelerate discovery of novel complex proteins through AI-guided design and high-throughput cell-free expression

PR Newswire associated0

LabConnect and OmniScience to Deliver First Agentic AI Solution for Real-Time Clinical Trial Lab Insights

ACCESSWIRE logo

BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development

Business Wire logo

Canada-UK Collaboration Developing AI-powered Bioreactors to Revolutionise Biopharmaceutical Manufacturing

Sofinnova.AI (Photo: Sofinnova)

Sofinnova Partners Unveils Sofinnova.AI: A Cutting-edge Artificial Intelligence Platform Set to Transform Its Life Sciences Investment Practice